Avantium has raised US$33.6m via an accelerated bookbuild offering
Avantium N.V. has raised US$33.6 million through an accelerated bookbuild offering of 5,206,589 new ordinary shares, representing approximately 19.99% of the company’s issued share capital. The shares have been placed at a price of US$6.42 (€5.35) per new ordinary share.
Avantium, founded in 2000 and headquartered in Amsterdam, is a leading technology development company and a forerunner in renewable chemistry. Together with its partners around the world, the company focuses on developing and commercializing breakthrough technologies for the production of chemicals from renewable sources and circular plastic materials used for a variety of consumer products. In addition, the company also provides advanced catalysis R&D services and systems to clients active in the refinery and chemical industries.
In January 2020, Avantium signed a letter of intent regarding its new FDCA flagship plant in Delfzijl, the Netherlands, for which it has currently signed five conditional offtake agreements for over 50% of its production capacity. The world’s first commercial FDCA plant will produce plant-based FDCA, a key building block for many chemicals and plastics such as PEF. The US$33.6 million capital increase marks an important step for Avantium towards a positive final investment decision for the construction of the plant.
Oaklins’ team in the Netherlands acted as financial advisor to Avantium and raised over 17% of pre-commitments.
Tom van Aken
CEO, Avantium N.V.
Talk to the deal team
Related deals
Xeros Technology Group has completed a placing, subscription and retail offer
Xeros Technology Group plc has raised funds to drive forward its commercialization strategy.
Learn morePCI Pal has completed an equity raise
PCI Pal has completed a fundraising. Funds will be allocated towards several key areas, with a significant portion directed towards supporting its continued expansion in the US, focusing on marketing efforts, product marketing and enhancing engagement with key partners.
Learn morePrestige Inhome Care has found a long-term strategic partner
Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.
Learn more